Characteristic | Total | HCC group | Non-HCC group | P -value |
---|---|---|---|---|
Patient (n = 460) | 460 | 302 | 158 | |
Mean age (years) * | 54.24 ± 11.32 | 56.05 ± 9.65 | 50.75 ± 13.31 | 0.061 |
Sex | 0.000 | |||
Male | 347 (75.4%) | 257 (85.1%) | 90 (57.0%) | |
Female | 113 (24.6%) | 45 (14.9%) | 68 (43.0%) | |
BMI | 23.6 (21.3–25.4) | 23.3 (20.9–24.4) | 23.7 (21.8–26.0) | 0.034 |
Cirrhosis | 0.000 | |||
Presence | 280 (60.9%) | 191(63.2%) | 89 (56.3%) | |
Absence | 180 (39.1%) | 111 (36.8%) | 69 (43.7%) | |
Cause of liver disease | 0.213 | |||
Hepatitis B virus | 368 (78.0%) | 253 (81.6%) | 115 (71.0%) | |
Hepatitis C virus | 62 (13.1%) | 37 (11.9%) | 25 (15.4%) | |
Alcohol | 29 (6.1%) | 11 (3.5%) | 18 (11.1%) | |
NASH | 13 (2.8%) | 9 (2.9%) | 4 (2.5%) | |
Child–Pugh Class | 0.000 | |||
Class A | 386 (83.9%) | 247 (81.8%) | 139 (88.0%) | |
Class B | 60 (13.0%) | 42 (13.9%) | 18 (11.4%) | |
Class C | 14 (3.0%) | 13 (4.3%) | 1 (0.6%) | |
Hepatic function index** | ||||
AST | 20.4 (29–50.7) | 29.3 (20.9–52) | 28.3 (18.5–40.1) | 0.188 |
ALT | 29.6 (21.9–47.9) | 30.3 (23-48.6) | 28.1 (20.6–46.8) | 0.044 |
TBIL (µmol/L) | 13.6 (9.9–20.2) | 14.7 (11.1–20.5) | 12.1 (8.8–17.5) | 0.000 |
PT | 12.3 (11.6–13.5) | 12.3 (11.7–13.5) | 12.2 (11.4–13.6) | 0.161 |
PLT | 143.7 (95.0–194.5) | 140.0(91.0–183.0) | 152.5 (111.8-218.7) | 0.007 |
AFP** | 5.83(2.7–43.1) | 13.1(3.3–143.8) | 3.1(1.9–5.98) | 0.000 |
Lesions(n = 473) | 473 | 311 | 162 | |
No. of nodules | 0.317 | |||
1 | 447 (94.5%) | 293(94.2%) | 154 (95.1%) | |
2 | 13 (6.6%) | 9 (2.9%) | 4 (2.5%) | |
Mean size (cm) | 2.91 ± 2.33 | 3.34 ± 1.75 | 2.08 ± 1.75 | 0.000 |
Degree of differentiation of HCC | ||||
Well differentiated | 54 (17.4%) | |||
Moderately differentiated | 161 (51.8%) | |||
Low-differentiated | 96 (30.9%) | |||
Standard reference of diagnosis | 0.000 | |||
Pathologic diagnosis | 355 (75.1%) | 311 (100%) | 44 (27.2%) | |
Typical imaging features with size stability | 118 (24.9%) | 0 (0%) | 118 (76.6%) |